fbpx

Day

November 3, 2014
Agreement enhances existing relationship between Celladon and Lonza for the manufacture of MYDICAR®Lonza to initiate design of a new commercial viral therapeutics facility in Portsmouth, NH (USA)         Celladon obtains option to trigger construction of facility and commit to long-term commercial supplyLonza to purchase $10 million of Celladon common stock upon Celladon's decision to trigger construction...

News

Maude has become the stereotypical migraine patient – but it’s not quite the true picture
31. July 2020
Ancient DNA throws a ‘scientific hand grenade’ into the discussion about the arrival of humans in North America
23. July 2020
Danish researchers map key disease mechanism – and describe a completely new protein
20. July 2020

Lundbeckfonden

Lundbeckfonden Ventures

Lundbeckfonden Emerge